Thiard News@F4F

@newsen.bsky.social

2 days ago

PanGIA Biotech's Innovative Cancer Detection Accepted at AACR 2026 Meeting PanGIA Biotech announces the acceptance of two abstracts on its non-invasive cancer detection system for the AACR Annual Meeting 2026, highlighting exciting developments.

PanGIA Biotech's Innovative Cancer Detection Accepted at AACR 2026 Meeting #United_States #San_Diego #cancer_detection #AACR_2026 #PanGIA_Biotech

Thiard News@F4F

@newsen.bsky.social

2 days ago

Harbinger Health Launches RESOLVE™: A Breakthrough in Cancer Detection Technology Harbinger Health has introduced RESOLVE™, a novel blood-based multi-cancer detection category, aiming to reduce delays in diagnosing cancers.

Harbinger Health Launches RESOLVE™: A Breakthrough in Cancer Detection Technology #United_States #Cambridge #cancer_detection #Harbinger_Health #RESOLVE™

Thiard News@F4F

@newsen.bsky.social

1 week ago

DELFI Diagnostics to Present Innovative Advances in Cancer Detection at AACR 2026 Annual Meeting At the AACR 2026, DELFI Diagnostics will unveil recent innovations in cancer detection using whole-genome cfDNA, covering lung cancer sustyping and treatment response.

DELFI Diagnostics to Present Innovative Advances in Cancer Detection at AACR 2026 Annual Meeting #United_States #San_Diego #DELFI_Diagnostics #cancer_detection #cfDNA_advances

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Helio Genomics Partners with Quest Diagnostics to Boost Accessibility of Liver Cancer Detection Test Helio Genomics has partnered with Quest Diagnostics to make its HelioLiver™ test widely accessible for early liver cancer detection through Quest's extensive network.

Helio Genomics Partners with Quest Diagnostics to Boost Accessibility of Liver Cancer Detection Test #United_States #Irvine #Quest_Diagnostics #cancer_detection #HelioLiver

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

VolitionRx Achieves Major Breakthrough in Liquid Biopsy with Over 99% Cancer DNA Purity VolitionRx Limited makes significant strides in liquid biopsy technology, achieving over 99% purity in isolating cancer-derived DNA, paving the way for early detection.

VolitionRx Achieves Major Breakthrough in Liquid Biopsy with Over 99% Cancer DNA Purity #United_States #Liquid_Biopsy #cancer_detection #VolitionRx #Henderson,_Nevada

Thiard News@F4F

@newsen.bsky.social

1 month ago

GRAIL Introduces Inducement Grants for Future Employees Under NASDAQ Rule GRAIL, Inc. has announced inducement grants under NASDAQ Rule 5635 for newly hired employees, emphasizing their mission to detect cancer early.

GRAIL Introduces Inducement Grants for Future Employees Under NASDAQ Rule #USA #Menlo_Park #RSUs #GRAIL #cancer_detection

Thiard News@F4F

@newsen.bsky.social

1 month ago

VolitionRx Reports Remarkable Progress in Cancer Detection and Veterinary Diagnostics VolitionRx Limited showcases impressive advancements in cancer detection and veterinary diagnostics, emphasizing innovative methods and significant partnerships.

VolitionRx Reports Remarkable Progress in Cancer Detection and Veterinary Diagnostics #USA #cancer_detection #VolitionRx #Henderson,_Nevada #VNRX

Thiard News@F4F

@newsen.bsky.social

1 month ago

GRAIL Announces Participation at TD Cowen Health Care Conference 2026 GRAIL, Inc. is set to present at the upcoming TD Cowen 46th Annual Health Care Conference, focusing on early cancer detection innovations.

GRAIL Announces Participation at TD Cowen Health Care Conference 2026 #United_States #Boston #GRAIL #cancer_detection #Health_Care

Thiard News@F4F

@newsen.bsky.social

1 month ago

GRAIL Announces Impressive Growth in 2025 Financial Outcomes with Cancer Detection Innovations In 2025, GRAIL, Inc. showcased significant growth in their cancer detection services, reporting a 26% increase in Galleri revenue, demonstrating advancements in early cancer detection technology.

GRAIL Announces Impressive Growth in 2025 Financial Outcomes with Cancer Detection Innovations #USA #Menlo_Park #GRAIL #cancer_detection #Galleri

Thiard News@F4F

@newsen.bsky.social

1 month ago

Global Breast Lesion Localization Methods Market Projected to Hit $3.6 Billion by 2033 with 11.7% CAGR Growth The breast lesion localization methods market is set to reach $3.6 billion by 2033, driven by advancements in technologies and rising breast cancer incidences.

Global Breast Lesion Localization Methods Market Projected to Hit $3.6 Billion by 2033 with 11.7% CAGR Growth #United_States #Wilmington #cancer_detection #Minimally_Invasive #Breast_Localization

Thiard News@F4F

@newsen.bsky.social

2 months ago

Mercy BioAnalytics Welcomes Darrin Crisitello as New Chief Commercial Officer Mercy BioAnalytics names Darrin Crisitello as Chief Commercial Officer. With over 20 years in the commercial sector, he aims to enhance cancer detection.

Mercy BioAnalytics Welcomes Darrin Crisitello as New Chief Commercial Officer #USA #Waltham #cancer_detection #Mercy_BioAnalytics #Darrin_Crisitello

Thiard News@F4F

@newsen.bsky.social

2 months ago

HT Vet's VISTA iQ™ Launches Innovative Cancer Detection for Pets, Boosting Veterinary Clinic Revenue HT Vet introduces VISTA iQ™, a revolutionary tool for early cancer detection in dogs, promising increased revenue for clinics and better healthcare outcomes.

HT Vet's VISTA iQ™ Launches Innovative Cancer Detection for Pets, Boosting Veterinary Clinic Revenue #United_States #cancer_detection #HT_Vet #VISTA_iQ #Hillside,_NJ

Thiard News@F4F

@newsen.bsky.social

3 months ago

Revolutionary N-NOSE® Cancer Test Launches New CM in Hokkaido and Aomori HIROTSU Bio Science begins airing a new commercial for its N-NOSE® cancer test, emphasizing early detection and public awareness in northern Japan.

Revolutionary N-NOSE® Cancer Test Launches New CM in Hokkaido and Aomori #Japan #Tokyo #cancer_detection #N-NOSE #HiROTSU_Bio

Thiard News@F4F

@newsen.bsky.social

3 months ago

Freenome and NVIDIA Partner to Revolutionize Multi-Cancer Detection Using AI Deep Learning Freenome combines forces with NVIDIA to enhance early cancer detection technology through AI and deep learning, facilitating personalized screening.

Freenome and NVIDIA Partner to Revolutionize Multi-Cancer Detection Using AI Deep Learning #USA #Brisbane #NVIDIA #cancer_detection #Freenome

Thiard News@F4F

@newsen.bsky.social

3 months ago

Freenome's Enhanced Colorectal Cancer Blood Test Achieves Significant Sensitivity Improvements Freenome reveals impressive advancements in its colorectal cancer blood test, showcasing an 85% sensitivity for CRC and improved detection rates for precancerous lesions, signaling a new era in early cancer diagnostics.

Freenome's Enhanced Colorectal Cancer Blood Test Achieves Significant Sensitivity Improvements #USA #Brisbane #cancer_detection #Freenome #CRC_Test

Thiard News@F4F

@newsen.bsky.social

4 months ago

GRAIL to Showcase Innovations in Early Cancer Detection at J.P. Morgan Conference GRAIL, Inc. will present at the 44th J.P. Morgan Healthcare Conference, sharing groundbreaking approaches to cancer detection and management.

GRAIL to Showcase Innovations in Early Cancer Detection at J.P. Morgan Conference #USA #San_Francisco #GRAIL #cancer_detection #Nasdaq_GRAL

Thiard News@F4F

@newsen.bsky.social

4 months ago

Yenos Analytical Unveils Revolutionary Urine Test for Early Cancer Detection Discover Yenos Analytical's groundbreaking urine test for early detection of multiple cancers, promising 97% accuracy. It's a game-changer in cancer diagnostics!

Yenos Analytical Unveils Revolutionary Urine Test for Early Cancer Detection #United_States #cancer_detection #El_Dorado_Hills #Yenos_Analytical #MCED_Test

Thiard News@F4F

@newsen.bsky.social

4 months ago

GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy A new study by GC Genome reveals critical physiological factors influencing cfDNA signals, paving the way to enhance liquid biopsy accuracy.

GC Genome's Study Uncovers Key Confounders Affecting Cancer Signal Detection in Liquid Biopsy #South_Korea #Liquid_Biopsy #Yongin #cancer_detection #GC_Genome

Thiard News@F4F

@newsen.bsky.social

4 months ago

Astrin Biosciences Unveils New Advisory Board to Enhance Early Cancer Detection with AI Innovations Astrin Biosciences has formed a Scientific Advisory Board with leading experts to expedite advancements in early cancer detection using AI and proteomics, aiming for routine Stage 0 identification.

Astrin Biosciences Unveils New Advisory Board to Enhance Early Cancer Detection with AI Innovations #United_States #AI_Technology #cancer_detection #St._Paul #Astrin_Biosciences

Thiard News@F4F

@newsen.bsky.social

4 months ago

GRAIL, Inc. Unveils New Inducement Grants for Non-Executive Employees GRAIL, Inc. has announced the granting of equity awards to recently hired non-executive employees under NASDAQ rules, aimed at early cancer detection.

GRAIL, Inc. Unveils New Inducement Grants for Non-Executive Employees #United_States #Inc. #Menlo_Park #RSUs #GRAIL #cancer_detection

Thiard News@F4F

@newsen.bsky.social

4 months ago

Peter Gilgan Donates $50 Million for Revolutionary Cancer Detection Program Peter Gilgan has made a groundbreaking donation of $50 million to establish the world's largest early cancer detection research program at Princess Margaret Cancer Centre.

Peter Gilgan Donates $50 Million for Revolutionary Cancer Detection Program #Canada #Toronto #cancer_detection #Peter_Gilgan #Princess_Margaret

Thiard News@F4F

@newsen.bsky.social

4 months ago

Development of Compact Sensor for Rapid Detection of Cancer Markers for Home Medical Monitoring A new compact sensor that quickly detects cancer markers like HSP90 is paving the way for early cancer detection and monitoring in home healthcare settings.

Development of Compact Sensor for Rapid Detection of Cancer Markers for Home Medical Monitoring #Japan #Tokyo #cancer_detection #Home_Healthcare #HSP90

Thiard News@F4F

@newsen.bsky.social

5 months ago

Dan Collins Joins TOBY as Advisor to Guide Cancer Detection Innovations TOBY, Inc. welcomes Dan Collins as an advisor to its Board to enhance cancer detection solutions with his international experience and expertise.

Dan Collins Joins TOBY as Advisor to Guide Cancer Detection Innovations #USA #Boston #cancer_detection #TOBY_Inc. #Dan_Collins

Thiard News@F4F

@newsen.bsky.social

5 months ago

GRAIL Reports Impressive Third Quarter Financial Results, Galleri Sees Significant Growth GRAIL, Inc. shares exciting financial updates for Q3 2025, showcasing significant growth in Galleri test sales and strategic collaborations aimed at expanding market reach.

GRAIL Reports Impressive Third Quarter Financial Results, Galleri Sees Significant Growth #USA #Menlo_Park #GRAIL #cancer_detection #Galleri

Thiard News@F4F

@newsen.bsky.social

5 months ago

Lunit Unifies Under One Brand, Transforming AI Cancer Detection and Care Lunit has rebranded Volpara Health Technologies, unifying its efforts in AI for cancer detection and treatment under a single identity to enhance patient care.

Lunit Unifies Under One Brand, Transforming AI Cancer Detection and Care #AI #South_Korea #Seoul #Lunit #cancer_detection

Thiard News@F4F

@newsen.bsky.social

5 months ago

GRAIL to Showcase Innovations in Early Cancer Detection at Wolfe Research Conference GRAIL, Inc. is set to present its groundbreaking work in early cancer detection at the Wolfe Research Healthcare Conference, highlighting innovative technologies.

GRAIL to Showcase Innovations in Early Cancer Detection at Wolfe Research Conference #United_States #Menlo_Park #Healthcare_Innovation #GRAIL #cancer_detection

Thiard News@F4F

@newsen.bsky.social

5 months ago

GRAIL, Inc. Secures $325 Million in Private Placement Financing to Advance Cancer Detection Technology GRAIL, Inc. announces a private placement financing of $325 million aimed at enhancing its cancer detection capabilities and operational funding.

GRAIL, Inc. Secures $325 Million in Private Placement Financing to Advance Cancer Detection Technology #United_States #Menlo_Park #GRAIL #cancer_detection #Private_Placement

Thiard News@F4F

@newsen.bsky.social

5 months ago

GRAIL PATHFINDER 2 Study Confirms Galleri Test Revolutionizes Cancer Detection with Remarkable Success GRAIL's PATHFINDER 2 study highlights the Galleri multi-cancer detection test's over seven-fold increase in cancer detection rates when combined with standard screenings. This innovation offers hope in early-stage cancer identification.

GRAIL PATHFINDER 2 Study Confirms Galleri Test Revolutionizes Cancer Detection with Remarkable Success #USA #Menlo_Park #GRAIL #cancer_detection #Galleri

Thiard News@F4F

@newsen.bsky.social

6 months ago

bioAffinity Technologies Secures $1.8 Million Financing Through WallachBeth Capital bioAffinity Technologies announces a $1.8 million financing deal led by WallachBeth Capital, focusing on its noninvasive lung cancer test.

bioAffinity Technologies Secures $1.8 Million Financing Through WallachBeth Capital #United_States #Jersey_City #cancer_detection #WallachBeth_Capital #bioAffinity_Technologies

Thiard News@F4F

@newsen.bsky.social

6 months ago

GRAIL Sets to Reveal Galleri® Insights From 32,000 Participants at ESMO Congress 2025 At the ESMO Congress 2025, GRAIL will present significant new findings on the Galleri® test's effectiveness from extensive clinical studies, helping to redefine early cancer detection.

GRAIL Sets to Reveal Galleri® Insights From 32,000 Participants at ESMO Congress 2025 #USA #Menlo_Park #GRAIL #cancer_detection #Galleri